163 related articles for article (PubMed ID: 3119651)
1. Evaluation of hypothalamic dysfunction in growth hormone (GH)-deficient patients using single versus multiple doses of GH-releasing hormone (GHRH-44) and evidence for diurnal variation in somatotroph responsiveness to GHRH in GH-deficient patients.
Schriock EA; Hulse JA; Harris DA; Kaplan SL; Grumbach MM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1177-82. PubMed ID: 3119651
[TBL] [Abstract][Full Text] [Related]
2. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
[TBL] [Abstract][Full Text] [Related]
3. A persistent pattern of varying pituitary responsivity to exogenous growth hormone (GH)-releasing hormone in GH-deficient children: evidence supporting periodic somatostatin secretion.
Martha PM; Blizzard RM; McDonald JA; Thorner MO; Rogol AD
J Clin Endocrinol Metab; 1988 Sep; 67(3):449-54. PubMed ID: 2900843
[TBL] [Abstract][Full Text] [Related]
4. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
Cordido F; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man.
Barbarino A; Corsello SM; Della Casa S; Tofani A; Sciuto R; Rota CA; Bollanti L; Barini A
J Clin Endocrinol Metab; 1990 Nov; 71(5):1368-74. PubMed ID: 2229294
[TBL] [Abstract][Full Text] [Related]
6. The effect of pulsatile administration, continuous infusion, and diurnal variation on the growth hormone (GH) response to GH-releasing hormone in normal men.
Hulse JA; Rosenthal SM; Cuttler L; Kaplan SL; Grumbach MM
J Clin Endocrinol Metab; 1986 Oct; 63(4):872-8. PubMed ID: 3091629
[TBL] [Abstract][Full Text] [Related]
7. Effects of intravenous, subcutaneous, and intranasal administration of growth hormone (GH)-releasing hormone-40 on serum GH concentrations in normal men.
Evans WS; Vance ML; Kaiser DL; Sellers RP; Borges JL; Downs TR; Frohman LA; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1985 Nov; 61(5):846-50. PubMed ID: 3930551
[TBL] [Abstract][Full Text] [Related]
8. Atenolol enhances nocturnal growth hormone (GH) release in GH-deficient children during long term GH-releasing hormone therapy.
Martha PM; Blizzard RM; Thorner MO; Rogol AD
J Clin Endocrinol Metab; 1990 Jan; 70(1):56-61. PubMed ID: 2104629
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
Tzanela M; Guyda H; Van Vliet G; Tannenbaum GS
J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
[TBL] [Abstract][Full Text] [Related]
10. The effects of acute and chronic growth hormone (GH) administration on GH secretion in patients with idiopathic GH deficiency.
Hanew K; Goh M; Sato S; Shimizu Y; Sasaki A; Aida M; Yoshinaga K
J Clin Endocrinol Metab; 1988 Apr; 66(4):715-21. PubMed ID: 3126213
[TBL] [Abstract][Full Text] [Related]
11. Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: a time-dependent effect.
Rosenthal SM; Kaplan SL; Grumbach MM
J Clin Endocrinol Metab; 1989 Jun; 68(6):1101-5. PubMed ID: 2498383
[TBL] [Abstract][Full Text] [Related]
12. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
Devesa J; Arce V; Lois N; Tresguerres JA; Lima L
J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
[TBL] [Abstract][Full Text] [Related]
13. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency.
Gelato MC; Ross JL; Malozowski S; Pescovitz OH; Skerda M; Cassorla F; Loriaux DL; Merriam GR
J Clin Endocrinol Metab; 1985 Sep; 61(3):444-50. PubMed ID: 3926806
[TBL] [Abstract][Full Text] [Related]
14. Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine.
Valcavi R; Valente F; Dieguez C; Zini M; Procopio M; Portioli I; Ghigo E
J Clin Endocrinol Metab; 1993 Sep; 77(3):616-20. PubMed ID: 8103770
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor.
Borges JL; Blizzard RM; Evans WS; Furlanetto R; Rogol AD; Kaiser DL; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1984 Jul; 59(1):1-6. PubMed ID: 6427267
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man.
Ghigo E; Goffi S; Nicolosi M; Arvat E; Valente F; Mazza E; Ghigo MC; Camanni F
J Clin Endocrinol Metab; 1990 Dec; 71(6):1481-5. PubMed ID: 2229304
[TBL] [Abstract][Full Text] [Related]
17. Effect of growth hormone (GH)-releasing hormone (GRH) on plasma GH in relation to magnitude and duration of GH deficiency in 26 children and adults with isolated GH deficiency or multiple pituitary hormone deficiencies: evidence for hypothalamic GRH deficiency.
Schriock EA; Lustig RH; Rosenthal SM; Kaplan SL; Grumbach MM
J Clin Endocrinol Metab; 1984 Jun; 58(6):1043-9. PubMed ID: 6427257
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects.
Aloi JA; Gertz BJ; Hartman ML; Huhn WC; Pezzoli SS; Wittreich JM; Krupa DA; Thorner MO
J Clin Endocrinol Metab; 1994 Oct; 79(4):943-9. PubMed ID: 7962302
[TBL] [Abstract][Full Text] [Related]
19. Low doses of either intravenously or orally administered arginine are able to enhance growth hormone response to growth hormone releasing hormone in elderly subjects.
Ghigo E; Ceda GP; Valcavi R; Goffi S; Zini M; Mucci M; Valenti G; Cocchi D; Müller EE; Camanni F
J Endocrinol Invest; 1994 Feb; 17(2):113-7. PubMed ID: 8006330
[TBL] [Abstract][Full Text] [Related]
20. The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion.
Eakman GD; Dallas JS; Ponder SW; Keenan BS
J Clin Endocrinol Metab; 1996 Mar; 81(3):1217-23. PubMed ID: 8772602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
